NPRA mission is to safeguard the nation’s health through scientific excellence in the regulatory control of medicinal products and cosmetics.
COVID-19
PRODUCT SEARCH
REPORTING OF SIDE EFFECTS TO MEDICINES OR VACCINES
New Products Approved |
Additional Indications Approved |
[Updated] Olmesartan: Risk of Autoimmune Hepatitis |
Proton Pump Inhibitors: Risk of Erectile Dysfunction |
Levetiracetam and Clobazam: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) |
23 Jul 2024; 08:00AM - 05:00PM MOPI Training 2024: Behavioural GMP and Data Integrity – essentials to know about minimising human error |
10 Jul 2024; 08:00AM - 05:00PM MOPI Training 2024: Introduction to Laboratory Controls and analytical Method validation – managing OOS/ OOT/ OOE, Basics about Analytical Method Validation |
25 Jun 2024; 08:00AM - 05:00PM MOPI Training 2024: Process Validation and application of Statistics in Validation |
11 Jun 2024; 08:00AM - 05:00PM MOPI Training 2024: Computer Systems for Regulated Environment |
15 May 2024; 08:30AM - 01:00PM [INVITATION] SEMINAR: ISPE Online GDP Seminar : Module 2 (Validation & Self-Inspection Requirement for GDP Compliance) |